Two Sigma Securities’s Celularity CELU Stock Holding History

Two Sigma Securities’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,866	Closed	-$19.8K	–	1792
2026 Q1	$19.8K	Buy	+14,866	New	+$18.8K	﹤0.01%	1371

Other funds holding CELU

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFO

Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

Two Sigma Securities's CELU Position: Q2 2026 in Review

Two Sigma Securities sold out of Celularity (CELU) in Q2 2026, closing a stake of 14,866 shares — an estimated $19.8K sold.

Two Sigma Securities first reported a position in CELU in Q1 2026 and held it in 1 quarter. The position peaked at $19.8K in Q1 2026. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

Two Sigma Securities reported no remaining Celularity position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 14,866 Celularity shares in Q2 2026, an estimated $19.8K.
Two Sigma Securities first reported a position in Celularity in Q1 2026 and held it in 1 quarter.
Two Sigma Securities's Celularity position peaked at $19.8K in Q1 2026.
39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.